New Trial: Alliance A231602CD Financial Toxicity (Blood Cancers) Trial

March 15, 2019

Alliance A231701CD - Assessing financial difficulty in patients with blood cancers

Alliance researcher Rena Conti, PhD, of the Boston University Questrom School of Business, leads a trial that seeks to better understand the range of financial difficulties experienced by patients with multiple myeloma (MM) or chronic lymphocytic leukemia (CLL) who are currently undergoing or have foregone treatmen

New Trial: Alliance A231701CD Decision Making Intervention Trial

March 5, 2019

Alliance A231701CD - Increasing socioeconomically disadvantaged patients' engagement in breast cancer surgery decision making through a shared decision making intervention

Alliance researcher Heather B. Neuman, MD, of the University of Wisconsin School of Medicine and Public Health, leads a limited access trial on how well a breast cancer surgery decision aid works in increasing patient engagement i

New Trial: Alliance A221701 Oral Stomatitis

February 22, 2019

Alliance A221701 - Phase III placebo-controlled trial to evaluate dexamethasone use for everolimus-induced oral stomatitis: Prevention versus early treatment approaches

Alliance researcher Kathryn J. Ruddy, MD, of Mayo Clinic, leads a new phase III trial looks at how well dexamethasone works in reducing everolimus-induced oral stomatitis in patients with cancer. Dexamethasone may help to reduce the everolimus-induced or

Older News